Cover Image

Study assesses normal tissue effects after axillary radiotherapy for early breast cancer

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Carrie Printz
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	CA: A Cancer Journal for Clinicians
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Regorafenib as maintenance therapy showed significant delayed progression of non‐adipocytic soft tissue sarcomas
by: Carrie Printz
Published: (2025)

Is active surveillance an alternative to surgery for some patients with esophageal cancer?
by: Carrie Printz
Published: (2025)

Fertility counseling for reproductive‐age women with cancer should address gestational carriers
by: Carrie Printz
Published: (2025)

PORTEC‐3 trial finds that adjuvant chemoradiotherapy significantly improves 10‐year survival for patients with high‐risk endometrial cancer
by: Carrie Printz
Published: (2026)

Immunotherapy combination shows longer progression‐free survival than chemotherapy alone for patients with a rare type of metastatic colorectal cancer
by: Carrie Printz
Published: (2025)

Chemotherapy‐induced taste changes affect nutrition, quality of life
by: Carrie Printz
Published: (2025)

People experiencing homelessness face inpatient care disparities
by: Carrie Printz
Published: (2025)

Active monitoring of DCIS shows promise in short‐term study
by: Carrie Printz
Published: (2025)

Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH ‐mutated anaplastic glioma
by: Carrie Printz
Published: (2026)

Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial
by: Ling‐Long Tang, et al.
Published: (2025)

Maintenance therapy after first‐line therapy for ovarian cancer: Quantitative effectiveness
by: Susana M. Campos, et al.
Published: (2025)

The association between menopausal hormone therapy and breast cancer remains unsettled
by: Mike Fillon
Published: (2024)

Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer
by: Akshara Singareeka Raghavendra, et al.
Published: (2026)

A patient with newly diagnosed breast cancer found to have mosaic TP53 likely pathogenic variant
by: Hetal D. Mistry, et al.
Published: (2025)

Pursuit of precision oncology in the treatment of metastatic hormone receptor–positive breast cancer: Making strides or barely moving?
by: Ilana Schlam, et al.
Published: (2026)

Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future
by: Alessandro Mannucci, et al.
Published: (2025)

Osimertinib prolongs progression‐free lung cancer survival after chemotherapy
by: Mike Fillon
Published: (2024)

Erectile dysfunction common within the first year after rectal cancer surgery
by: Mike Fillon
Published: (2025)

Cancer treatment and survivorship statistics, 2025: An urgent call to optimize health after cancer
by: Lidia Schapira, et al.
Published: (2025)

Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management
by: Maxime Borgeaud, et al.
Published: (2025)

Colon cancer blood test effective for average‐risk population
by: Mike Fillon
Published: (2024)

The evolving landscape of tissue‐agnostic therapies in precision oncology
by: Vivek Subbiah, et al.
Published: (2024)

Breast cancer: The good, the bad, and an important call to effective risk reduction strategies
by: Virginia G. Kaklamani, et al.
Published: (2024)

Targeting tumor suppressor gene co‐mutations in EGFR ‐mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification
by: Krishna S. Gunturu, et al.
Published: (2026)

Study identifies risk factors that may lead to secondary cancers
by: Mike Fillon
Published: (2024)

Twenty‐year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I–III breast cancer
by: Orit Kaidar‐Person, et al.
Published: (2026)

Overlooked barriers to implementation of geriatric assessment
by: Banu E. Symington, et al.
Published: (2024)

Screening for colorectal cancer
Published: (2026)

Geriatric assessment for the practicing clinician: The why, what, and how
by: Allison Magnuson, et al.
Published: (2024)

Prostate cancer statistics, 2025
by: Tyler B. Kratzer, et al.
Published: (2025)

Comprehensive management of vulvovaginal cancers
by: Angélica Nogueira‐Rodrigues, et al.
Published: (2025)

Colorectal cancer statistics, 2026
by: Rebecca L. Siegel, et al.
Published: (2026)

Breast cancer statistics 2024
by: Angela N. Giaquinto, et al.
Published: (2024)

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
by: Freddie Bray, et al.
Published: (2024)

Breast cancer in a transgender man
by: Alison May Berner, et al.
Published: (2025)

Learning from prostate cancer statistics
by: Ruth Etzioni, et al.
Published: (2025)

More care needed for cancer caregivers
by: Mike Fillon
Published: (2024)

Update and new advances in fertility preservation and cancer
by: Gwendolyn P. Quinn, et al.
Published: (2025)

Key issues face AI deployment in cancer care
by: Mike Fillon
Published: (2024)

Most patients with cancer are not undergoing germline genetic testing
by: Mike Fillon
Published: (2024)